Ariana – Recordati announced that it has successfully completed the acquisition of 23% shares in Opalia Pharma SA, a pharmaceutical company based in Ariana, near Tunis. Now Recordati holds 90% of Opalia Pharma SA shares, while the remaining 10% is held by Alya El Hedda, who is one of the founders and Director General of Opalia Pharma. Opalia Pharma, founded in 1988, ranks tenth in the Tunisian pharmaceutical market and is the third national pharmaceutical company. Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange, with approximately 4,000 employees. Based in Milan, it operates mainly in Europe, and has contracts in Russia and other countries of Central and Eastern Europe, Turkey, North Africa and the United States. (9Colonne)
